Traumatic brain injury is caused by a sudden harm to the cerebrum because of injury, mishap, strikes, or sports wounds. Genuine damage could bring about harm to a specific piece of the cerebrum, prompting traumatic brain injuries. It is described by disarray, dim or obscured vision, discourse debilitation, tipsiness, as well as absence of awareness. The injury can be grouped into gentle, direct, or extreme, contingent on the state of the patient and side effects related with the episode. Patients experiencing such cerebrum damage are closely observed with the assistance of different strategies to assess the technique and course of treatment and the viability of the continuous treatment in diminishing the impacts of the damage in patients.
Increasing traumatic brain injuries due to increase in number of incidence, initiation of new procedures, for instance, brain tissue oxygen checking devices in brain injury patients, new gadget endorsements in the U.S., and Europe, and surging number of clinical preliminaries for assessment of new procedures and gadgets for observing brain injuries is fueling the market. As indicated by the Centers for Disease Control and Prevention (CDC), an expected 1.4 million individuals in the U.S. sustain brain injuries, prompting around 50,000 deaths and an expected 235,000 hospitalizations every year. In addition, lack of monitoring devices along with lack of non-invasive devices in the market is expected to create growth opportunities for key players of the market.
The global traumatic brain injuries assessment and management devices market is segmented into device type, technique, end-use, and region. The device segmented is further sub-segmented into magnetic resonance imaging, computed tomography devices, x-ray, and others. On the basis of technique, the market is segmented into intracranial pressure monitoring, and partial pressure of oxygen in brain tissue. The end-use segment is categorized into diagnostic imaging centers, hospitals, and others.
The key players of this market include BioDirection, Inc., QuesGen Systems, Inc., BrainScope Company, Inc., and Neural Analytics, Inc.
Avail customized purchase options to meet your exact research needs:
Get your queries resolved from an industry expert.
Design an exclusive study to serve your research needs.
A testimonial for service in the form of BBB "A" Accreditation.
Your personal and confidential information is safe and secure.
"The quality of research they have done for us has been excellent..."